CR
Corbus Pharmaceuticals Holdings, Inc.
CRBP · NASDAQ
$7.48 +2.33% (+$0.17)
1M -23.98%
Market Cap $134.5M
P/E Ratio -
Div. Yield -
ROE 87.05%
Bulios Fair Price
$9.69
29.5% upside
Trenutna cena
$7.48
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica CRBP trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
1/9Valuation
100 /100
Cheap P/B 1.32x
P/E N/A
EV/EBITDA N/A
Growth
100 /100
Growing Book val. growth 64.74%
EPS growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
0 /100
Poor ROIC 100.35%
ROE 87.05%
ROA 80.25%
Debt
100 /100
Low Debt/Equity 0.04x
Current ratio 5.71x
Int. coverage N/A
Stability
10 /100
Unstable Beta 2.64x
EPS volatility 62.35%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o CRBP
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Yuval Cohen
Employees
36
Headquarters
Norwood
Prihajajoči dogodki
11 NOV.
Earnings
Upcoming earnings report